Aurinia Pharmaceuticals, Inc. (AUPH)
16.58
-0.07
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
16.58
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Total Liabilities (Quarterly) : 177.40M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 177.40M |
| March 31, 2026 | 156.37M |
| December 31, 2025 | 189.26M |
| September 30, 2025 | 161.76M |
| June 30, 2025 | 167.26M |
| March 31, 2025 | 154.66M |
| December 31, 2024 | 173.17M |
| September 30, 2024 | 161.36M |
| June 30, 2024 | 158.91M |
| March 31, 2024 | 157.16M |
| December 31, 2023 | 170.11M |
| September 30, 2023 | 163.14M |
| June 30, 2023 | 156.61M |
| March 31, 2023 | 61.35M |
| December 31, 2022 | 65.42M |
| September 30, 2022 | 64.87M |
| June 30, 2022 | 58.38M |
| March 31, 2022 | 58.78M |
| December 31, 2021 | 64.28M |
| September 30, 2021 | 61.89M |
| June 30, 2021 | 54.01M |
| March 31, 2021 | 46.85M |
| December 31, 2020 | 55.91M |
| September 30, 2020 | 62.91M |
| June 30, 2020 | 56.24M |
| Date | Value |
|---|---|
| March 31, 2020 | 51.56M |
| December 31, 2019 | 53.17M |
| September 30, 2019 | 27.10M |
| June 30, 2019 | 25.37M |
| March 31, 2019 | 25.16M |
| December 31, 2018 | 33.29M |
| September 30, 2018 | 32.35M |
| June 30, 2018 | 25.68M |
| March 31, 2018 | 23.96M |
| December 31, 2017 | 24.10M |
| September 30, 2017 | 32.19M |
| June 30, 2017 | 29.34M |
| March 31, 2017 | 47.03M |
| December 31, 2016 | 21.05M |
| September 30, 2016 | 13.15M |
| June 30, 2016 | 10.65M |
| March 31, 2016 | 11.72M |
| December 31, 2015 | 13.60M |
| September 30, 2015 | 15.40M |
| June 30, 2015 | 16.37M |
| March 31, 2015 | 20.45M |
| December 31, 2014 | 7.272M |
| September 30, 2014 | 7.079M |
| June 30, 2014 | 9.106M |
| March 31, 2014 | 8.655M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| enGene Therapeutics, Inc. | 52.36M |
| Medicus Pharma Ltd. | 20.33M |
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 53.38M |
| Psyence Biomedical Ltd. | 0.9431M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 792.26M |
| Shareholders Equity (Quarterly) | 614.86M |
| Debt to Equity Ratio | 0.1043 |
| Current Ratio | 5.419 |
| Net Debt Paydown Yield | 0.12% |